Alveolar surfactant protein D content modulates bleomycin-induced lung injury.
about
Proteome changes in human bronchoalveolar cells following styrene exposure indicate involvement of oxidative stress in the molecular-response mechanismLow-dose AgNPs reduce lung mechanical function and innate immune defense in the absence of cellular toxicityS-nitrosylation of surfactant protein-D controls inflammatory functionSelective inhibition of inducible NO synthase activity in vivo reverses inflammatory abnormalities in surfactant protein D-deficient mice.Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury.Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-βSegmental allergen challenge alters multimeric structure and function of surfactant protein D in humans.Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome.Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.Surfactant dysfunction and lung inflammation in the female mouse model of lymphangioleiomyomatosisThe role of inducible nitric oxide synthase for interstitial remodeling of alveolar septa in surfactant protein D-deficient mice.Update in critical care 2005.Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional studyIncreased surfactant protein D fails to improve bacterial clearance and inflammation in serpinB1-/- miceHIV antiretroviral therapy reduces circulating surfactant protein-D levels.Immunomodulatory roles of surfactant proteins A and D: implications in lung disease.Surfactant protein D protects against acute hyperoxic lung injury.Dynamics of lung macrophage activation in response to helminth infection.Simultaneous absence of surfactant proteins A and D increases lung inflammation and injury after allogeneic HSCT in mice.Role of NOS2 in pulmonary injury and repair in response to bleomycin.Surfactant protein D: a lung specific biomarker in COPD?S-nitrosylation of surfactant protein D as a modulator of pulmonary inflammation.Danger-associated molecular patterns (DAMPs) in acute lung injury.Differential modulation of surfactant protein D under acute and persistent hypoxia in acute lung injury.Acute pulmonary response of mice to multi-wall carbon nanotubes.Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D.Surfactant replacement therapy reduces acute lung injury and collapse induration-related lung remodeling in the bleomycin model.Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury.Analysis of pulmonary surfactant in rat lungs after intratracheal instillation of short and long multi-walled carbon nanotubes.SP-D-deficient mice are resistant to hyperoxia.Exposure to Silver Nanospheres Leads to Altered Respiratory Mechanics and Delayed Immune Response in an in Vivo Murine Model.Smoking and polymorphisms of genes encoding mannose-binding lectin and surfactant protein-D in patients with rheumatoid arthritis
P2860
Q28389343-2264D3A4-150A-4F87-90E2-1DBB0F3A75C9Q28389887-03F7A3F0-8459-4C4B-9B5C-6B84A6A4ACEDQ33384274-B3DE9E72-C76D-42DB-81C9-D7A48B7DE912Q33564627-CA317672-8B38-4930-8C50-44F4C6E6EDBBQ33593887-6727A356-9E38-4206-9CF3-18EE204EEC08Q34004876-074C4A46-309B-492C-83BE-51B8378FD9BBQ34676557-E77B63DC-AA36-4DC2-8046-31225DFCDCF3Q34914727-E167FCE4-C85F-431D-9D68-11145CFEE8FEQ35219750-4A8D10CC-6980-4B20-AF39-99CFB383EDD5Q35813675-F16CAFF1-E0CE-4F44-9FA4-017A6337B9FFQ36049475-30AE97FC-2CDF-452B-9FB7-47411EE4C129Q36237212-B258D7EB-3292-41AC-BBD2-E43B6A51D93DQ36442993-83DFAF0C-745E-4DE7-996F-B1327ACC25A3Q36473600-7A9DA71C-2D4F-41ED-949F-3F37505B521AQ36539597-DC363777-7F1D-49F6-968F-31237EE2E980Q36776685-9A8E2F18-BE14-4B19-9E2E-C37CEEB48ACFQ36868290-A08C9CB9-DD87-468B-94F0-F82F71C8D5BDQ36935241-5BB9096B-5D68-4EA9-844A-DF0CA86EBE93Q37039002-82CE3869-A3CB-4106-B71B-9F15A7C6ED8DQ37100510-3369F449-2176-49F8-A37C-4C7BABEAE294Q37330783-032FCB60-B338-4824-ACD1-B3D4FCBE371EQ37362594-A6E49D92-E6AD-49D4-84A2-D8C65B5EEC7DQ37969905-B57EB753-B2F7-41E1-9B4E-7D85382938F1Q38055437-EEEA3CCF-1D57-4A36-A160-B90596DFEEEEQ39353187-66B89BBC-573A-4328-A821-B6B4890876BFQ39910871-BBD123E7-D3F4-4483-B183-65F8A2553343Q41501070-29587380-F527-4DDB-956B-F4DDB1031415Q47908597-23B83ED7-FB66-445D-9250-72FD1EFAE0FCQ51368117-CEF277D6-3457-4F11-819E-71505503F401Q51508798-70DBFA01-2FD2-4F93-96CC-7BD744FBBD39Q52575551-D2DA2AB8-5F81-4F25-91C4-DF606A570904Q53697030-191ABDD6-37FA-4943-910F-80EDE3B2A324Q57422855-CB87A98B-24E7-4C4A-B616-7DAB5687E3E5
P2860
Alveolar surfactant protein D content modulates bleomycin-induced lung injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alveolar surfactant protein D content modulates bleomycin-induced lung injury.
@en
Alveolar surfactant protein D content modulates bleomycin-induced lung injury.
@nl
type
label
Alveolar surfactant protein D content modulates bleomycin-induced lung injury.
@en
Alveolar surfactant protein D content modulates bleomycin-induced lung injury.
@nl
prefLabel
Alveolar surfactant protein D content modulates bleomycin-induced lung injury.
@en
Alveolar surfactant protein D content modulates bleomycin-induced lung injury.
@nl
P2093
P2860
P1476
Alveolar surfactant protein D content modulates bleomycin-induced lung injury.
@en
P2093
Elena N Atochina-Vasserman
Helchem Kadire
James H Fisher
Jennifer Kaplan
John Casey
Michael F Beers
Rashmin C Savani
Samuel Hawgood
Yaniv Tomer
P2860
P304
P356
10.1164/RCCM.200505-767OC
P407
P577
2005-06-30T00:00:00Z